Matinas BioPharma (MTNB) announced the appointment of biotech industry veterans Keith Murphy and Edward Neugeboren to its Board of Directors as ...

Matinas BioPharma Holdings, Inc. (NYSE American: MTNB) today announced the appointment of biotech industry veterans Keith ...

NEW YORK - Investment firm 111 Equity Group, LLC and its principal have increased their collective ownership stake in Matinas Biopharma Holdings, Inc. (NYSE American: MTNB) to... 111 Equity Group ...

LAUPHEIM, Germany, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, today announced the ...

The approval of efsubaglutide alfa highlights China's growing role as a biopharma powerhouse. Over the past three decades, China's pharmaceutical industry has shifted from focusing primarily on raw ...

Matinas BioPharma Holdings, Inc. - GlobeNewswire - Thu Feb 13, 4:00PM CST BEDMINSTER, N.J., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE ...

1 Day MTNB 1.55% DJIA -0.37% Russell 2K -0.10% Health Care/Life Sciences 0.69% ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Biopharma deal activity in the first month of the year saw the largest January raise thus far, with $28.63 billion in collective funds. While down slightly month over month, the value was comparable ...